Doximity, Inc. (NASDAQ:DOCS) Holdings Lifted by Venturi Wealth Management LLC

Venturi Wealth Management LLC raised its position in Doximity, Inc. (NASDAQ:DOCS) by 20,421.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,746 shares of the company’s stock after purchasing an additional 5,718 shares during the quarter. Venturi Wealth Management LLC’s holdings in Doximity were worth $307,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the business. UMB Bank n.a. increased its position in Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after acquiring an additional 235 shares during the period. Farther Finance Advisors LLC grew its stake in shares of Doximity by 324.2% in the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after purchasing an additional 603 shares in the last quarter. Morse Asset Management Inc acquired a new position in shares of Doximity during the third quarter valued at $46,000. Covestor Ltd raised its stake in shares of Doximity by 441.9% during the third quarter. Covestor Ltd now owns 1,680 shares of the company’s stock valued at $73,000 after purchasing an additional 1,370 shares in the last quarter. Finally, GAMMA Investing LLC lifted its holdings in Doximity by 20.6% in the fourth quarter. GAMMA Investing LLC now owns 1,735 shares of the company’s stock worth $93,000 after purchasing an additional 296 shares during the period. Institutional investors own 87.19% of the company’s stock.

Analyst Ratings Changes

DOCS has been the topic of several research analyst reports. Mizuho raised their target price on shares of Doximity from $55.00 to $65.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Bank of America raised their price objective on shares of Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a research note on Monday, January 6th. Canaccord Genuity Group boosted their target price on Doximity from $60.00 to $71.00 and gave the stock a “hold” rating in a report on Friday, February 7th. Canaccord Genuity Group lowered Doximity from a “buy” rating to a “hold” rating and increased their price target for the company from $40.00 to $60.00 in a research note on Wednesday, November 13th. Finally, Needham & Company LLC boosted their price objective on Doximity from $65.00 to $82.00 and gave the stock a “buy” rating in a research note on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $64.22.

Doximity Trading Down 2.1 %

DOCS stock opened at $75.10 on Friday. Doximity, Inc. has a one year low of $22.96 and a one year high of $85.21. The firm has a 50-day moving average of $59.79 and a two-hundred day moving average of $48.73. The firm has a market capitalization of $14.02 billion, a PE ratio of 75.10, a P/E/G ratio of 4.26 and a beta of 1.39.

Insider Activity

In other news, Director Timothy S. Cabral sold 20,000 shares of the firm’s stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares of the company’s stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 37.40% of the stock is owned by company insiders.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.